The suppressive effects of 6-dehydro-16-methylene-hydrocortisone (STC 407) 
with the usual corticosteroids given in doses associated with tolerable side effects. Indeed, Jailer et al. (1953) showed that administration of cortisone to patients with Cushing's syndrome reduced 17-ketosteroid excretion but without achieving a reduction in cortisol levels. The attempt by Cope (1956) to treat Cushing's syndrome with 9a-fluorohydrocortisone was no more successful. Christy et al. (1956) using prednisone, were unable to achieve any lasting de¬ pression of elevated cortisol production. Similar results were reported by Mallingly (1964) with dexamethasone, which had been used to diagnostic ad¬ vantage by Liddle (1960) in the well-known dexamethasone suppression test. Although in early therapy with some of the above steroids there was sometimes a suppression of ACTH production, this was followed after a few days by an escape of the hypophysis from the suppressive effect. It Assay of pituitary ACTH content. Assay rats, male, 130-160 g, were hypophysecto¬ mized transauricularly 4 h before an injection of the pituitary extracts. The extracts were prepared about 1 h before injection as follows: after thawing, the anterior pituitary glands were homogenized and then extracted with 0.9 % saline solution con¬ taining 0.2 % gelatine and 10°/o 0.1 n HC1. After centrifugation at 10 000 rpm at 4°C, the supernatant was diluted so that 0.2 ml contained 0.1 mg pituitary tissue. ACTH standard (ACTHAR, Armour) was given in doses of 0.2 and 0.4 mU/100 g b. w. Fifteen minutes after iv injection, the rats were decapitated; the blood was col¬ lected from the trunk into heparinized tubes, the plasma was separated and stored at -25°C until used for corticosterone determination.
Assay of hypothalamic CRF activity content. One hour before the assay the SME tissues were thawed, homogenized and extracted with O.t acetic acid. After spinning at 4°C at 10 000 rpm, the supernatant was separated, diluted to an appropriate con¬ centration and injected iv into assay rats. The assay was performed as described by Arimura et al. (1967) using the chlorpromazine-morphine-Nembutal-treated rats. The SME extracts were given to the assay rats at 2 dose levels. Fifteen minutes after iv injection of the SME extracts the rats were sacrificed, the blood was collected as above and the plasma stored at -25°C for corticosterone determination which was used as an index of CRF activity.
Corticosterone was determined fluorometrically (Guillemin et al. 1958) Finney (1964 ,:~4 rats from each group were sacrificed. 
